Merck
Experts play down Inergy cancer risk
September 5, 2008Sales and Marketing Merck, cv
Heart specialists have told patients to continue taking Schering-Plough and Merck's cholesterol-lowering drug Inergy, despite a study indicating that it …
Schering-Plough to buy Organon for 11 billion euros
March 21, 2007Sales and Marketing Merck, Schering-Plough
Schering-Plough is to buy Organon BioSciences by the end of this year, in an €11 billion cash deal.The acquisition will …
Cholesterol drugs boost Schering-Plough
February 9, 2007Sales and Marketing Merck, Schering-Plough
A 60% increase in sales of its cholesterol drugs franchise has helped Schering-Plough to post strong growth for 2006.Ezetrol and …
Markets stunned as Merck withdraws blockbuster Vioxx
September 30, 2004Merck, Vioxx
Merck has taken the pharmaceutical world by surprise by announcing the immediate withdrawal of its blockbuster arthritis pain drug Vioxx …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
October 26, 2026
